AlivaMab Biologics
Biotechnology Research • 
San Diego, California, United States • 21-50 Employees
Company overview
| Headquarters | 10581 Roselle Street, San Diego, California 92121, US |
| Phone number | +18588669310 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Antibody Therapeutics, Protein Expression And Purification, Antibody Drug Conjugates, Antibody Engineering, Hybridoma, Bispecific Antibodies, Transgenic Mouse, Antibody Discovery, Antibody Therapies, Monoclonal Antibody Discovery, Developability Assessment, Antibody Discovery Services, Cellular Immunization, Dna Immunization, Functional Antibody Leads, Protein Immunization |
| Employees | 21-50 |
| Socials |
Key Contacts at AlivaMab Biologics
Larry Green
Chief Executive Officer
Khyati Kapoor
Associate Director, Protein Sciences
Dana Duey
Director, Business Development
John Jones
Associate Director, Antibody Engineering
Crystal Bantados
Head Of Project Management Office, Sr. Director
Tracy Charlton
Associate Director, Antibody Discovery
AlivaMab Biologics Email Formats
AlivaMab Biologics uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@alivamab.com), used 51.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@alivamab.com | 51.5% |
{first initial}{last name} | jdoe@alivamab.com | 36.4% |
{last name}{last name} | doedoe@alivamab.com | 12.1% |
About AlivaMab Biologics
AlivaMab Biologics provides fully integrated solutions for biologics drug discovery through our continuously expanding platform of innovative capability modules. Our most recent additions to our capability modules include drug discovery for fully human single-domain VH, common light chain multispecific antibodies, and TCR mimic antibodies. AMB’s customizable capability modules include target validation, protein- and cell-based tool engineering and production, sophisticated functional assay development and execution, discovery of binding domains using Ablexis’ suite of AlivaMab Mouse strains, kinetic and epitope characterization, protein and antibody engineering across a breadth of novel biologic drug modalities, full-depth developability assessment, antibody optimization, and production up to medium scale. AMB’s partners also gain from the team’s direct experience and know-how in the discovery and development of biologics drugs across various modalities. Partners may select to work with AMB across the full spectrum of capability modules or to pick and choose across them. AlivaMab Biologics sets its partners’ biologics programs on the path to success with the fastest and most de-risked solutions through discovery and development.
AlivaMab Biologics revenue & valuation
| Annual revenue | $2,908,870 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
AlivaMab Biologics has 16 employees across 3 departments.
Departments
Number of employees
Funding Data
AlivaMab Biologics has never raised funding before.
AlivaMab Biologics Tech Stack
Discover the technologies and tools that power AlivaMab Biologics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Miscellaneous
Cookie compliance
JavaScript libraries
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Analytics
Programming languages
Denmark
Italy
Portugal
Frequently asked questions
4.8
40,000 users
